Shiyao Du
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Corrigendum to "Lipophilic recombinant-protein insertion endows lymphocytes with enhanced targeting-infiltration ability in EGFR positive cancer" [Cell. Immunol. 365 (2021) 104376].
Journal: Cellular immunology
Published: July 07, 2026
Membrane fusogenic nanoparticle-based HLA-peptide-addressing universal T cell receptor-engineered T (HAUL TCR-T) cell therapy in solid tumor.
Journal: Bioengineering & translational medicine
Published: January 10, 2023
Neoantigen-targeted TCR-T cell therapy for solid tumors: How far from clinical application.
Journal: Cancer letters
Published: May 23, 2022
Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation.
Journal: Journal for immunotherapy of cancer
Published: April 02, 2021
Lipophilic recombinant-protein insertion endows lymphocytes with enhanced targeting-infiltration ability in EGFR positive cancer.
Journal: Cellular immunology
Published: February 22, 2021
Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells.
Journal: International journal of nanomedicine
Published: October 15, 2019
Immune-Mediated Antitumor Effect By VEGFR2 Selective Inhibitor For Gastric Cancer.
Journal: OncoTargets and therapy
Published: October 05, 2019
iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer.
Journal: Nature communications
Published: January 18, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026